Literature DB >> 16531792

Short-term reproducibility of a non-dipping pattern in type 2 diabetic hypertensive patients.

Cesare Cuspidi1, Stefano Meani, Laura Lonati, Veronica Fusi, Cristiana Valerio, Carla Sala, Gaia Magnaghi, Meilikemu Maisaidi, Alberto Zanchetti.   

Abstract

BACKGROUND: Little information is available on the reproducibility of nocturnal variations in blood pressure in type 2 diabetic hypertensive patients.
OBJECTIVE: We aimed to compare the intrasubject short-term reproducibility of a nocturnal non-dipping pattern and the prevalence of cardiac and extracardiac signs of target organ damage, in a group of type 2 diabetic hypertensive patients and in an age/gender-matched group of non-diabetic hypertensive subjects.
METHODS: Thirty-six treated hypertensive patients with long-lasting type 2 diabetes (> 10 years duration) consecutively attending our hospital out-patient hypertension clinic (group I; mean age, 65 +/- 9 years), and 61 untreated non-diabetic subjects with grade 1 and grade 2 uncomplicated essential hypertension, matched for age and gender, and chosen from patients attending an outpatient clinic (group II; mean age, 65 +/- 5 years), were considered for this analysis. All patients underwent blood sampling for routine blood chemistry, 24-h urine collection for microalbuminuria, two 24-h periods of ambulatory blood pressure monitoring (ABPM) within a 4-week period, echocardiography, and carotid ultrasonography. A dipping pattern was defined as a greater than 10% reduction in the average systolic and diastolic blood pressure at night compared with average daytime values.
RESULTS: A reproducible nocturnal dipping and non-dipping profile was found in 11 (30.6%) and 21 (58.3%) diabetic patients, respectively; while only in four (11.1%) patients was a variable dipping profile observed. Of the 23 patients with a non-dipping pattern during the first ABPM period, 21 (91.3%) also had this type of pattern during the second ABPM recording. In group II (non-diabetic hypertensive patients), 30 patients (49.2%, P < 0.05) had a dipping pattern, 13 patients (21.3%, P < 0.01) had a non-dipping profile pattern and 18 patients (29.5%, P < 0.01) had a variable dipping pattern. Of the 20 patients with a non-dipping pattern during the first ABPM period, 13 (65.0%) confirmed this type of pattern during the second ABPM recording. Finally, the prevalence of left ventricular hypertrophy (77.7 versus 41.4%, P < 0.01), carotid plaques (80.5 versus 38.3%, P < 0.01), carotid intima-media thickening (54.3 versus 44.0%, P < 0.05) and microalbuminuria (11.1 versus 2.0%, P < 0.01) was significantly higher in group I than in group II. According to a logistic regression analysis, diabetes, left ventricular hypertrophy and carotid plaques were the main independent predictors of the non-dipping (pattern in the overall population.
CONCLUSIONS: These findings indicate that intrasubject variability of non-dipper pattern is lower in diabetic than in non-diabetic hypertensive patients, that classification of diabetic hypertensive patients as dipper or non-dipper on the basis of a single ABP recording is more reliable than in non-diabetic patients, and that the more frequent and reproducible non-dipping (pattern in diabetic patients is associated with a more prominent cardiac and extracardiac target organ damage.

Entities:  

Mesh:

Year:  2006        PMID: 16531792     DOI: 10.1097/01.hjh.0000217846.65089.19

Source DB:  PubMed          Journal:  J Hypertens        ISSN: 0263-6352            Impact factor:   4.844


  21 in total

1.  Intensified monitoring of circadian blood pressure and heart rate before and after intravitreous injection of bevacizumab: preliminary findings of a pilot study.

Authors:  Focke Ziemssen; Qi Zhu; Swaantje Peters; Salvatore Grisanti; Mohammed El Wardani; Peter Szurman; Karl U Bartz-Schmidt; Tjalf Ziemssen
Journal:  Int Ophthalmol       Date:  2008-04-17       Impact factor: 2.031

Review 2.  Chronotherapeutics of conventional blood pressure-lowering medications: simple, low-cost means of improving management and treatment outcomes of hypertensive-related disorders.

Authors:  Ramón C Hermida; Diana E Ayala; Michael H Smolensky; José R Fernández; Artemio Mojón; Juan J Crespo; María T Ríos; Ana Moyá; Francesco Portaluppi
Journal:  Curr Hypertens Rep       Date:  2014-02       Impact factor: 5.369

Review 3.  Sleep, slow-wave sleep, and blood pressure.

Authors:  Sogol Javaheri; Susan Redline
Journal:  Curr Hypertens Rep       Date:  2012-10       Impact factor: 5.369

Review 4.  Ambulatory blood pressure improves prediction of cardiovascular risk: implications for better antihypertensive management.

Authors:  Lawrence R Krakoff
Journal:  Curr Atheroscler Rep       Date:  2013-04       Impact factor: 5.113

5.  Sleep-time BP: prognostic marker of type 2 diabetes and therapeutic target for prevention.

Authors:  Ramón C Hermida; Diana E Ayala; Artemio Mojón; José R Fernández
Journal:  Diabetologia       Date:  2015-09-23       Impact factor: 10.122

6.  Nocturnal nondipping of heart rate predicts cardiovascular events in hypertensive patients.

Authors:  Kazuo Eguchi; Satoshi Hoshide; Joji Ishikawa; Thomas G Pickering; Joseph E Schwartz; Kazuyuki Shimada; Kazuomi Kario
Journal:  J Hypertens       Date:  2009-11       Impact factor: 4.844

Review 7.  Chronotherapy with conventional blood pressure medications improves management of hypertension and reduces cardiovascular and stroke risks.

Authors:  Ramón C Hermida; Diana E Ayala; Michael H Smolensky; José R Fernández; Artemio Mojón; Francesco Portaluppi
Journal:  Hypertens Res       Date:  2015-12-10       Impact factor: 3.872

8.  Ambulatory blood pressure is a better marker than clinic blood pressure in predicting cardiovascular events in patients with/without type 2 diabetes.

Authors:  Kazuo Eguchi; Thomas G Pickering; Satoshi Hoshide; Joji Ishikawa; Shizukiyo Ishikawa; Joseph E Schwartz; Kazuyuki Shimada; Kazuomi Kario
Journal:  Am J Hypertens       Date:  2008-02-21       Impact factor: 2.689

9.  Hypertension and disrupted blood pressure circadian rhythm in type 2 diabetic db/db mice.

Authors:  Wen Su; Zhenheng Guo; David C Randall; Lisa Cassis; David R Brown; Ming C Gong
Journal:  Am J Physiol Heart Circ Physiol       Date:  2008-08-15       Impact factor: 4.733

10.  Masked nocturnal hypertension--a novel marker of risk in type 2 diabetes.

Authors:  M Wijkman; T Länne; J Engvall; T Lindström; C J Ostgren; F H Nystrom
Journal:  Diabetologia       Date:  2009-04-25       Impact factor: 10.122

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.